Gurkan, E. Et Al. 2014. Evaluation of exenatide versus insulin glargine for the impact on endothelial functions and cardiovascular risk markers. DIABETES RESEARCH AND CLINICAL PRACTICE , vol.106, no.3 , 567-575.

Gurkan, E., TARKUN, İ., ŞAHİN, T., Cetinarslan, B., & CANTÜRK, Z., (2014). Evaluation of exenatide versus insulin glargine for the impact on endothelial functions and cardiovascular risk markers. DIABETES RESEARCH AND CLINICAL PRACTICE , vol.106, no.3, 567-575.

Gurkan, Eren Et Al. "Evaluation of exenatide versus insulin glargine for the impact on endothelial functions and cardiovascular risk markers," DIABETES RESEARCH AND CLINICAL PRACTICE , vol.106, no.3, 567-575, 2014

Gurkan, Eren Et Al. "Evaluation of exenatide versus insulin glargine for the impact on endothelial functions and cardiovascular risk markers." DIABETES RESEARCH AND CLINICAL PRACTICE , vol.106, no.3, pp.567-575, 2014

Gurkan, E. Et Al. (2014) . "Evaluation of exenatide versus insulin glargine for the impact on endothelial functions and cardiovascular risk markers." DIABETES RESEARCH AND CLINICAL PRACTICE , vol.106, no.3, pp.567-575.

@article{article, author={Eren Gurkan Et Al. }, title={Evaluation of exenatide versus insulin glargine for the impact on endothelial functions and cardiovascular risk markers}, journal={DIABETES RESEARCH AND CLINICAL PRACTICE}, year=2014, pages={567-575} }